00:00Daily vitamin C was linked to better three-year survival in a small blood disorder trial.
00:05These patients have conditions that can turn into acute myeloid leukemia and aggressive blood cancer.
00:11No approved treatment can stop one of these conditions from progressing to leukemia.
00:15The Phase II trial enrolled 109 patients at four hospitals, including one in Southern California.
00:22One group took 1,000 mg of vitamin C by mouth every day for 12 months.
00:27The other took a look-alike placebo in a double-blind design.
00:30More than half the patients started the trial with low vitamin C levels.
00:35The vitamin C group also had fewer adverse events during the study and follow-up.
00:39Vitamin C did not slow the growth of the abnormal blood cells.
00:43The survival result came from an exploratory analysis and needs a larger trial to confirm.
00:48For now, daily vitamin C is a promising lead, not a proven treatment.
00:53Disclosure.
00:53This video contains stock footage and content created or enhanced using AI-assisted tools.
